This study suggests that SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 may be potential targets for the clinical diagnosis, prognosis, and treatment of ccRCC patients. The gene discussed is SLC25A4; the disease is nonpapillary renal cell carcinoma.